GovWire

Class 4 Medicines Defect Information: Thornton & Ross Ltd, Methadone 1mg/mL Oral Solution BP - Sugar Free, Methadone Mixture 1mg/ml , EL(23)A/07

Medicines Healthcare Products Regulatory Agency

March 7
11:03 2023

MDR number

MDR 146-02/23

Company name

Thornton & Ross Ltd

Product name

Methadone 1mg/mL Oral Solution BP - Sugar Free, PL 00240/0044

SNOMED Code

5196111000001108

Batch No Expiry Date Pack Size First Distributed
16LY 31/10/2025 6 x 500mL 21 Dec 2022
45LX 31/10/2025 6 x 500mL 17 Jan 2023
47LX 31/10/2025 6 x 500mL 27 Jan 2023
48LX 31/10/2025 6 x 500mL 03 Feb 2023
87MA 30/11/2025 6 x 500mL Not yet distributed
90MA 30/11/2025 6 x 500mL Not yet distributed
91MA 30/11/2025 6 x 500mL Not yet distributed
08MB 30/11/2025 6 x 500mL Not yet distributed
00MC 30/11/2025 6 x 500mL Not yet distributed
44MD 31/12/2025 6 x 500mL Not yet distributed
96MC 31/12/2025 6 x 500mL Not yet distributed
92MA 31/12/2025 6 x 500mL Not yet distributed
53MC 31/12/2025 6 x 500mL Not yet distributed
52MC 31/12/2025 6 x 500mL Not yet distributed
98MC 31/12/2025 6 x 500mL Not yet distributed
99MC 31/12/2025 6 x 500mL Not yet distributed
97MC 31/12/2025 6 x 500mL Not yet distributed

Active Pharmaceutical Ingredient: methadone hydrochloride

Product name

Methadone Mixture 1mg/mL, PL 00240/0039

SNOMED Code

337711000001108

Batch No Expiry Date Pack Size First Distributed
19LY 31/10/2025 6 x 500mL Not yet distributed
17LY 31/10/2025 6 x 500mL Not yet distributed
18LY 31/10/2025 6 x 500mL Not yet distributed
21LY 31/10/2025 6 x 500mL Not yet distributed
20LY 31/10/2025 6 x 500mL Not yet distributed
47MB 30/11/2025 6 x 500mL Not yet distributed
19MB 30/11/2025 6 x 500mL Not yet distributed
16MB 30/11/2025 6 x 500mL Not yet distributed

Active Pharmaceutical Ingredient: methadone hydrochloride

Brief description of the problem

Thornton & Ross Ltd has informed the MHRA that specific batches of Methadone 1mg/mL Oral Solution BP Sugar Free have been packaged with the incorrect Product Information Leaflet (PIL). The incorrect PIL is missing important safety information. Please see Appendix 1 (Page 4-6 of the Class 4 Medicines Defect Notification) for full details of the missing information including the text in the current (erroneous) version of the leaflet packaged within the affected batches and the subsequent correct PIL text.

The batches listed as not yet distributed have also been packaged with the incorrect PIL and this affects both Methadone 1mg/mL Oral Solution BP Sugar Free and Methadone Mixture 1mg/mL. The MHRA, in discussion with the Department of Health and Social Care, considers these products critical for patients, therefore these batches will not be repackaged and continue to be distributed. They are therefore included in the notification.

Advice for healthcare professionals

There is no risk to product quality as a result of this issue and the affected batches on the market are not being recalled. Supervised consumption of methadone means that it is usually administered in the presence of a healthcare professional, who can advise the patient on important safety information and precautions.

For dispensing of products from all affected batches, healthcare professionals are advised to discuss the missing information with patients and provide a copy of the updated PIL, where appropriate. The missing information in the PIL provides additional safety information related to dependency, addiction, and withdrawal reactions; potential effects on hormones; safety information about pregnancy and breastfeeding; and potential interactions with other medicines. Links to the correct PILs are provided below:

Methadone 1mg/mL Oral Solution BP - Sugar Free: https://www.medicines.org.uk/emc/product/4905/pil

Methadone Mixture 1mg/mL: https://www.medicines.org.uk/emc/product/4907/pil

Advice for patients

The Patient Information Leaflet (PIL) included in the pack with the above batches of these medicines does not contain the most up to date safety information. We have asked healthcare professionals to discuss the latest safety information with patients who are receiving medicines from these batches. Patients can also read the updated sections highlighted in Appendix 1 or read the updated version of the PIL available online (links above).

You should not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. If you have any questions about your medicine or changes to the PIL or are concerned about side effects, talk to your healthcare professional. The quality of the medicine itself is not affected. As for all medicines, any suspected adverse reactions should also be reported via the MHRAs Yellow Card scheme.

Further Information

For medical information queries please contact thorntonross@medinformation.co.uk. Upon request, Thornton & Ross Ltd will provide hard copies of the updated PIL to pharmacy teams.

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Yours faithfully

Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU

Telephone +44 (0)20 3080 6574

DMRC@mhra.gov.uk

Download document

Class 4 Medicines Defect Information: Thornton & Ross Ltd, Methadone 1mg/mL Oral Solution BP - Sugar Free, Methadone Mixture 1mg/ml , EL(23)A/07

Published 7 March 2023

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

News Calendar

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: